Demo environment — synthetic patient data. Integration-ready; payer connectivity requires customer or partner configuration.
PreRelay™

Providers

Know what is blocked — and what to do next

PreRelay™ surfaces waiting-on party, blocked reason, and required action so clinical teams never chase a vague “pending” status.

When a dose escalation (for example Mounjaro 7.5 mg → 10 mg) triggers prior authorization, providers see the medication continuity timeline and can attest previous dosage evidence against the same Case ID pharmacies and payers use.

Sprint 0 demonstrates this with synthetic data only: TEST PATIENT 001 / Mounjaro — no real PHI.